Concepedia

Osteochondrodystrophic Lesions in Chelated Thalassemic Patients: An Histological Analysis

Vincenzo De Sanctis, Susanna Stea, L. Savarino, Donatella Granchi, M. Visentin, Monica Sprocati, R. Govoni, A. Pizzoferrato

Calcified Tissue International · 2000 · 27 citations · 17 references

DOI

Concepts

References

17

Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions

Nancy F. Olivieri, J. Raymond Buncic, Emily Chew et al. · New England Journal of Medicine · 1986 · 431 citations

, , +17

Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major

Gary M. Brittenham, Christine E. McLaren, Douglas M. Templeton et al. · New England Journal of Medicine · 1998 · 420 citations · Full text

, , +17

Deferoxamine-induced growth retardation in patients with thalassemia major

Stefano De Virgillis, Mauro Congia, Fulvia Frau et al. · The Journal of Pediatrics · 1988 · 210 citations

, , +12

High prevalence of low bone mass in thalassaemia major

Jensen, Tuck, Agnew et al. · British Journal of Haematology · 1998 · 177 citations · Full text

, , +16

Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major

Naomi Bronspiegel-Weintrob, Nancy F. Olivieri, Beverley J. Tyler et al. · New England Journal of Medicine · 1990 · 169 citations · Full text

, , +16